(Q45888620)

17 December 2017

review article

1 reference

title

Gene therapy for leukemia and lymphoma (English)

1 reference

17 December 2017

0 references

S W Adams

1

1 reference

17 December 2017

S G Emerson

series ordinal

2

1 reference

17 December 2017

language of work or name

1 reference

1 June 1998

1 reference

17 December 2017

Hematology / Oncology Clinics of North America

published in

1 reference

17 December 2017

volume

12

1 reference

17 December 2017

issue

3

1 reference

17 December 2017

page(s)

631-648

1 reference

17 December 2017

Ex vivo treatment of bone marrow with phosphorothioate oligonucleotide OL(1)p53 for autologous transplantation in acute myelogenous leukemia and myelodysplastic syndrome

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970012-5

7 January 2021

HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970012-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970012-5

1 reference

7 January 2021

Autologous bone marrow transplant for children with AML in first complete remission: use of marker genes to investigate the biology of marrow reconstitution and the mechanism of relapse

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970012-5

7 January 2021

Gene-marking to trace origin of relapse after autologous bone-marrow transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970012-5

7 January 2021

Assessment of the efficacy of purging by using gene marked autologous marrow transplantation for children with AML in first complete remission

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970012-5

7 January 2021

Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970012-5

7 January 2021

Normal and leukemic hematopoietic cells manifest differential sensitivity to inhibitory effects of c-myb antisense oligodeoxynucleotides: an in vitro study relevant to bone marrow purging

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970012-5

7 January 2021

Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970012-5

7 January 2021

Retroviral gene transfer in autologous bone marrow transplantation for adult acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970012-5

7 January 2021

Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970012-5

7 January 2021

Frequency analysis of multidrug resistance-1 gene transfer into human primitive hematopoietic progenitor cells using the cobblestone area-forming cell assay and detection of vector-mediated P-glycoprotein expression by rhodamine-123.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970012-5

7 January 2021

An efficient deletion mutant packaging system for defective herpes simplex virus vectors: potential applications to human gene therapy and neuronal physiology.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970012-5

7 January 2021

Phosphorothioate oligodeoxynucleotides bind to basic fibroblast growth factor, inhibit its binding to cell surface receptors, and remove it from low affinity binding sites on extracellular matrix

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970012-5

7 January 2021

Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970012-5

7 January 2021

Protective and therapeutic immunity against leukemia induced by irradiated B7-1 (CD80)-transduced leukemic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970012-5

7 January 2021

The bioactivation of CB 1954 and its use as a prodrug in antibody-directed enzyme prodrug therapy (ADEPT).

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970012-5

7 January 2021

Comparison of different ribozymes for efficient and specific cleavage of BCR/ABL related mRNAs.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970012-5

7 January 2021

Retrovirus-mediated gene transfer of rat glutathione S-transferase Yc confers in vitro resistance to alkylating agents in human leukemia cells and in clonogenic mouse hematopoietic progenitor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970012-5

7 January 2021

Ribozymes cleave the AML1/MTG8 fusion transcript and inhibit proliferation of leukemic cells with t(8;21).

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970012-5

7 January 2021

Minimal sequence requirements for ribozyme activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970012-5

7 January 2021

The t(8;21) fusion protein interferes with AML-1B-dependent transcriptional activation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970012-5

7 January 2021

Vaccinia virus expression vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970012-5

7 January 2021

In vivo retrovirus-mediated herpes simplex virus thymidine kinase gene therapy approach for adult T cell leukemia in a rat model

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970012-5

7 January 2021

Cytokine gene transduction in the immunotherapy of cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970012-5

7 January 2021

In vivo treatment of human leukemia in a scid mouse model with c-myb antisense oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970012-5

7 January 2021

The role of the MDR1 (P-glycoprotein) gene in multidrug resistance in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970012-5

7 January 2021

Molecular genetics of childhood leukemias

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970012-5

7 January 2021

Cure of mice with established metastatic friend leukemia cell tumors by a combined therapy with tumor cells expressing both interferon-alpha 1 and herpes simplex thymidine kinase followed by ganciclovir

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970012-5

7 January 2021

Leukemia treatment in severe combined immunodeficiency mice by antisense oligodeoxynucleotides targeting cooperating oncogenes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970012-5

7 January 2021

Suppression of Philadelphia1 leukemia cell growth in mice by BCR-ABL antisense oligodeoxynucleotide

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970012-5

7 January 2021

Antileukemia effect of c-myc N3'-->P5' phosphoramidate antisense oligonucleotides in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970012-5

7 January 2021

Does antisense exist?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970012-5

7 January 2021

BCL-2 antisense therapy in patients with non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970012-5

7 January 2021

Experimental tumor therapy in mice using the cyclophosphamide-activating cytochrome P450 2B1 gene

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970012-5

7 January 2021

The retinoblastoma protein and cell cycle control

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970012-5

7 January 2021

Development and characterization of recombinant adenoviruses encoding human p53 for gene therapy of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970012-5

7 January 2021

10.1016/S0889-8588(05)70012-5

Identifiers

DOI

1 reference

17 December 2017

1 reference

17 December 2017